xtalpi

Keep you updated

with the latest info of XtalPi

Enhanced QM/MM sampling for free energy calculation of chemical reactions: A case study of double proton transfer
Understanding the entropic effect in chorismate mutase reaction catalyzed by isochorismate-pyruvate lyase from Pseudomonas aeruginosa (PchB)†
Harnessing Cloud Architecture for Crystal Structure Prediction Calculations
Tuning peptide self-assembly by an in-tether chiral center
CHARMM Drude Polarizable Force Field for Glycosidic Linkages Involving Pyranoses and Furanoses
Proper balance of solvent-solute and solute-solute interactions in the treatment of the diffusion of glucose using the Drude polarizable force field
Lead Identification – Discovering Selective Inhibitors Against an Unreported Binding Pocket of SMARCA2 via a Rational Drug Design Approach
hit discovery
XtalPi’s AI Platform Validated as Partner Companies Secure IND Approvals and Major Funding
XtalPi Debuts on HKEX Main Board as First 18C Listing, Pioneering AI + Robotics Innovation
XtalGazer | Advanced Solid State Research for Drug Discovery
XtalPi Launches XtalGazer™: Revolutionizing Drug Crystallization with AI-Driven Precision
Dr. Ma Jian Meets Hong Kong Chief Executive John Lee, Signs MoU with Hetao Shenzhen-Hong Kong Innovation Cooperation Zone
Singapore Deputy Prime Minister Heng Swee Keat Visits XtalPi, Commends AI-Driven Innovations

Search XtalPi

Unlock Faster, Smarter Polymorph Screening with XtalGazer™ CSP
Unlock Faster, More Accurate Drug Discovery with XFEP
Templated Nucleation of Clotrimazole and Ketoprofen on Polymer Substrates

XtalPi Newsletter